SMS Pharmaceuticals Ltd's Vizag plant receives WHO Geneva prequalification

SMS Pharmaceuticals Limited (SMS Pharma) (NSE: SMSPHARMA; BSE: 532815) is pleased to share that our Unit VII manufacturing facility in Visakhapatnam, Andhra Pradesh, has received prequalification approval from the World Health Organisation (WHO) Geneva. This significant milestone enhances our global regulatory standing and enables the company to increase its presence in the global market for Anti-Retroviral (ARV) APIs.

Commenting on this achievement, Mr. P. Vamsi Krishna, Executive Director, stated: "The WHO Geneva prequalification reflects the company's strong compliance with stringent international regulatory standards, reinforcing its reputation for quality, reliability, and global competitiveness."

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 239.55 as compared to the previous close of Rs. 235.15. The total number of shares traded during the day was 4862 in over 488 trades.

The stock hit an intraday high of Rs. 246.40 and intraday low of 234.00. The net turnover during the day was Rs. 1168233.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals INE812G01025 Unit7 Visakhapatnam AP PrequalificationApproval WHO Geneva